436 related articles for article (PubMed ID: 23806580)
1. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
[TBL] [Abstract][Full Text] [Related]
2. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
3. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia.
Asevedo E; Rizzo LB; Gadelha A; Mansur RB; Ota VK; Berberian AA; Scarpato BS; Teixeira AL; Bressan RA; Brietzke E
Physiol Behav; 2014 Apr; 129():194-8. PubMed ID: 24576679
[TBL] [Abstract][Full Text] [Related]
4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
5. Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia.
Niitsu T; Shirayama Y; Matsuzawa D; Hasegawa T; Kanahara N; Hashimoto T; Shiraishi T; Shiina A; Fukami G; Fujisaki M; Watanabe H; Nakazato M; Asano M; Kimura S; Hashimoto K; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1836-40. PubMed ID: 21930178
[TBL] [Abstract][Full Text] [Related]
6. Declarative memory and WCST-64 performance in subjects with schizophrenia and healthy controls.
Egan GJ; Hasenkamp W; Wilcox L; Green A; Hsu N; Boshoven W; Lewison B; Keyes MD; Duncan E
Psychiatry Res; 2011 Jul; 188(2):191-6. PubMed ID: 21481945
[TBL] [Abstract][Full Text] [Related]
7. Relations between a computerized shopping task and cognitive tests in a group of persons diagnosed with schizophrenia compared with healthy controls.
Larøi F; Canlaire J; Mourad H; VAN DER Linden M
J Int Neuropsychol Soc; 2010 Jan; 16(1):180-9. PubMed ID: 19900350
[TBL] [Abstract][Full Text] [Related]
8. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
Meiron O; Hermesh H; Katz N; Weizman A
Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
[TBL] [Abstract][Full Text] [Related]
9. Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia.
Carlino D; Leone E; Di Cola F; Baj G; Marin R; Dinelli G; Tongiorgi E; De Vanna M
J Psychiatr Res; 2011 Feb; 45(2):273-9. PubMed ID: 20630543
[TBL] [Abstract][Full Text] [Related]
10. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.
Dias VV; Brissos S; Frey BN; Andreazza AC; Cardoso C; Kapczinski F
Bipolar Disord; 2009 Sep; 11(6):663-71. PubMed ID: 19689509
[TBL] [Abstract][Full Text] [Related]
11. Gender difference in association of cognition with BDNF in chronic schizophrenia.
Zhang XY; Chen DC; Tan YL; Tan SP; Wang ZR; Yang FD; Xiu MH; Hui L; Lv MH; Zunta-Soares GB; Soares JC
Psychoneuroendocrinology; 2014 Oct; 48():136-46. PubMed ID: 24999831
[TBL] [Abstract][Full Text] [Related]
12. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity.
Pedrini M; Massuda R; Fries GR; de Bittencourt Pasquali MA; Schnorr CE; Moreira JC; Teixeira AL; Lobato MI; Walz JC; Belmonte-de-Abreu PS; Kauer-Sant'Anna M; Kapczinski F; Gama CS
J Psychiatr Res; 2012 Jun; 46(6):819-24. PubMed ID: 22520512
[TBL] [Abstract][Full Text] [Related]
13. Redox dysregulation, immuno-inflammatory alterations and genetic variants of BDNF and MMP-9 in schizophrenia: Pathophysiological and phenotypic implications.
Ali FT; Abd El-Azeem EM; Hamed MA; Ali MAM; Abd Al-Kader NM; Hassan EA
Schizophr Res; 2017 Oct; 188():98-109. PubMed ID: 28100419
[TBL] [Abstract][Full Text] [Related]
14. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
15. Verbal memory impairment in healthy siblings of patients with schizophrenia.
Massuda R; Bücker J; Czepielewski LS; Narvaez JC; Pedrini M; Santos BT; Teixeira AS; Souza AL; Vasconcelos-Moreno MP; Vianna-Sulzbach M; Goi PD; Belmonte-de-Abreu P; Gama CS
Schizophr Res; 2013 Nov; 150(2-3):580-2. PubMed ID: 24035560
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of cysteine in patients with schizophrenia: A potential marker of cognitive function preservation.
Wang LJ; Lin PY; Lee Y; Huang YC; Wu CC; Hsu ST; Chen CC; Chong MY; Lin CH; Hung CF
Schizophr Res; 2018 Feb; 192():391-397. PubMed ID: 28363347
[TBL] [Abstract][Full Text] [Related]
17. Verbal memory intrusions in schizophrenia: associations with self-reflectivity, symptomatology, and neurocognition.
Fridberg DJ; Brenner A; Lysaker PH
Psychiatry Res; 2010 Aug; 179(1):6-11. PubMed ID: 20638729
[TBL] [Abstract][Full Text] [Related]
18. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
Kake TR; Garrett N; Te Aonui M
Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
[TBL] [Abstract][Full Text] [Related]
19. Cognitive inhibition and working memory in unipolar depression.
Gohier B; Ferracci L; Surguladze SA; Lawrence E; El Hage W; Kefi MZ; Allain P; Garre JB; Le Gall D
J Affect Disord; 2009 Jul; 116(1-2):100-5. PubMed ID: 19042027
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
